Joel Lexchin

Showing all 2 results

Title & Subtitle Abstract Contributors Pages Year Purchase
From

The TPP and the Regulation of Medicines in Canada

From: The Trans-Pacific Partnership and Canada

Preview

explore the implications of the TPP for drug costs resulting from the agreement’s provisions on intellectual property, services and investment. 18 $1.80 Add
From

Pharmacare:

Equity, Efficiency, and Effectiveness — We’ve Waited Long Enough.

From: Medicare

Preview

Analyzes the debate about pharmacare by noting the similarity between how we fund perscription drugs and the way America funds their entire health care system and notes our rejection of this … 8 $0.80 Add